Skip to main content

Chlorothiazide Oral Tablets and Suspension Shortage

Last Updated: December 23, 2019
Status: Resolved

Products Affected - Description
    • Chlorothiazide oral tablet, Hikma, 500 mg, bottle, 100 count, NDC 00143-1210-01 - discontinued
    • Chlorothiazide oral tablet, Hikma, 500 mg, bottle, 1000 count, NDC 00143-1210-10 - discontinued
    • Chlorothiazide oral tablet, Mylan, 250 mg, bottle, 100 count, NDC 00378-0150-01 - discontinued
    • Chlorothiazide oral tablet, Mylan, 500 mg, bottle, 100 count, NDC 00378-0162-01 - discontinued
Reason for the Shortage
    • Mylan discontinued chlorothiazide tablets in September 2019.
    • Hikma discontinued chlorothiazide tablets.
    • Bausch health did not provide a reason for the shortage.
Available Products
    • Diuril oral suspension, Bausch Health, 250 mg / 5 mL 237 mL bottle, NDC 65649-0311-12

Estimated Resupply Dates

    • Bausch Health has Diuril suspension in 237 mL bottles available.

Updated

Updated December 23, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 4, 2019 by Rachael Freeman, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer